Analysis of the efficacy of thalidomide plus dexamethasone-based regimens in patients with relapsed/refractory multiple myeloma who received prior chemotherapy, including bortezomib and lenalidomide: KMM-166 study
Jung, Ki Sun, Kim, Kihyun, Kim, Hyo Jung, Kim, Sung hyun, Lee, Jeong-Ok, Kim, Jin Seok, Lee, Je-Jung, Eom, Hyeon-Seok, Min, Chang-Ki, Shin, Ho-JinLanguage:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.10.017
Date:
October, 2019
File:
PDF, 1.57 MB
english, 2019